Evolus (NASDAQ: EOLS) reported Q4 EPS of $0.00, $0.04 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $90.3 million versus the consensus estimate of $90.75 million.

GUIDANCE:

Evolus sees FY2026 revenue of $327-337 million, versus the consensus of $329.7 million.

For earnings history and earnings-related data on Evolus (EOLS) click here.